Orthocell


Orthocell is dedicated to developing regenerative medicine therapies that support the body's own repair mechanisms. They focus on innovative solutions for nerve repair, tissue regeneration, and complex injuries, with a strong emphasis on commercializing life-changing products. The company is ASX-listed, with a history of high growth potential and a global presence, including regulatory approvals and a broad distributor network. Their mission is to redefine nerve repair and advance regenerative medicine to improve patient outcomes worldwide.

Industries

biotechnology
medical
therapeutics

Nr. of Employees

small (1-50)

Orthocell

Melville, Western Australia, Australia, Oceania


Products

Remplir

Implantable nerve repair device designed to support peripheral nerve regeneration and improve functional recovery compared to standard suture techniques.


Services

Practitioner engagement and clinical adoption support

Partnerships with healthcare professionals, provision of surgical support and professional education to facilitate adoption of regenerative-medicine devices.

Commercial distribution and market access management

Establishment and coordination of regional distributor networks and market rollouts for medical devices.

Expertise Areas

  • Regenerative medicine
  • Peripheral nerve repair and reconstruction
  • Biomaterial scaffold engineering
  • Medical device development and commercialization
  • Show More (3)

Key Technologies

  • Collagen-based scaffold biomaterials
  • Implantable nerve repair conduits
  • Tissue-engineering scaffold design
  • Clinical study methodologies for device evaluation
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.